CareDx, Inc. CDNA

Rank #2329 · Nasdaq · $4.5B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

24.4

P/E

-23.7

P/B

10.48

ROE

-44.2%

Op. Margin

-72.5%

Debt Ratio

26%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -23.7x, P/B 10.48x. Ranks in the top 80% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -44.2%. Ranks in the top 88% of the universe.

Safety ★★★★☆

Excellent

Debt ratio 26%. Ranks in the top 15% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆

Poor

Revenue decline of 12.9% year over year. Ranks in the top 86% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2014	$0.0B	$-0.0B	$-0.0B	$-0.1B	-11.5	-18
2015	$0.0B	$-0.0B	$-0.0B	$-0.1B	-3.9	-13
2016	$0.0B	$0.0B	$0.0B	$0.0B	4.6	89
2017	$0.0B	$-0.0B	$-0.0B	$0.0B	-42.4	292
2018	$0.0B	$-0.0B	$-0.0B	$-0.0B	-91.9	-1459
2019	$0.0B	$-0.0B	$-0.1B	$0.1B	-42.0	36
2020	$0.1B	$-0.0B	$-0.0B	$0.1B	-20.3	53
2021	$0.1B	$-0.0B	$-0.0B	$0.3B	-19.3	33
2022	$0.2B	$-0.0B	$-0.0B	$0.5B	-11.7	22
2023	$0.3B	$-0.0B	$-0.0B	$0.3B	-10.0	40
2024	$0.3B	$-0.1B	$-0.1B	$0.5B	-24.0	44
2025	$0.3B	$-0.2B	$-0.2B	$0.4B	-72.5	26